James Philip Brock, D.O.
NPI 1871859611ActiveIndividual· Pediatrics, Pediatric Pulmonology· Denver, CO
Pediatrics, Pediatric Pulmonology (D.O.) in Denver, Colorado, licensed in CO and CA, with an NPI issued in April 2012. Enrolled in Medicare as practitioner - pulmonary disease. Boehringer Ingelheim Pharmaceuticals, Inc. was the largest of 3 companies reporting payments in 2025, $290.56 in all, mostly food and beverage.
Overview
| NPI | 1871859611 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | D.O. |
| Sole proprietor | No |
| NPI issued | Apr 5, 2012 |
| Last updated in NPPES | Apr 30, 2021 |
| Certified by provider | Apr 30, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pediatrics, Pediatric Pulmonology Primary | 2080P0214X | DR.0064907 | CO |
| Pediatrics, Pediatric Pulmonology | 2080P0214X | 20A13058 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (CO) |
|---|
Industry payments (Open Payments)
- 2025$290.56 · 4 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $135.00 | 1 |
| Astrazeneca Pharmaceuticals LP | $131.71 | 2 |
| 3b Medical, Inc. | $23.85 | 1 |
What the 2025 payments were for
- Food and Beverage$290.56 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Pediatrics, Pediatric Pulmonology providers in Denver
- 1235259169
- 1346278801
- 1710973532
- 1215083837
- 1336239532
- 1962518555